课题基金基金详情
纳秒脉冲电场消融协同氧化铁纳米粒子治疗肝癌的疗效及其免疫学机理实验研究
结题报告
批准号:
81971713
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
孙军辉
依托单位:
学科分类:
介入医学与工程
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
孙军辉
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
纳秒脉冲电场(nsPEF)消融使肿瘤细胞凋亡,同时可通过免疫效应抑制肿瘤远处转移。超顺磁性氧化铁(SPIO)纳米粒子能诱导巨噬细胞产生抗肿瘤非特异性免疫。我们前期研究发现nsPEF局部消融肝癌后,可产生局部和全身免疫反应,消融区域周围巨噬细胞增加并吞噬肿瘤细胞。本研究拟通过体外实验观察nsPEF和/或SPIO刺激巨噬细胞诱导分化、抗原表位改变、特异性及非特异性免疫反应因子变化;观察nsPEF、SPIO以及诱导后巨噬细胞对肝癌细胞生物学行为及抗原改变的影响。将SPIO纳米粒子经静脉注入nsPEF局部消融后的肝癌荷瘤动物体内,检测nsPEF引起的以肿瘤相关巨噬细胞改变为主的免疫效应及其机制;采用MR活体监测SPIO在肝癌及周围组织分布,验证SPIO抗肿瘤免疫作用;观察二者协同治疗肝癌的效果,明确二者是否具有协同诱导抗肿瘤免疫作用及可能机理,为提高肝癌等恶性肿瘤综合介入治疗效果提供新思路。
英文摘要
Nanosecond pulsed electric field (nsPEF) can cause apoptosis of tumor cell and inhibit distant metastasis of tumor by immunological effect. Superparamagnetic iron oxide (SPIO) nanoparticles can induce macrophages to produce synergistic antitumor immune reaction. Our previous study indicated that local nsPEF ablation of liver cancer can produce local and systemic immune responses, increase macrophages aggregation around the ablation area and phagocytose tumor cells. This study intends to observe the induction of differentiation, epitope changes, specific and non-specific immunological response factors of macrophages stimulated by nsPEF and/or SPIO in vitro, and to observe the biological behavior and the effects of antigenic changes of hepatocellular carcinoma cells stimulated by nsPEF and induced macrophages. The SPIO nanoparticles are injected intravenously into the tumor-bearing animals after nsPEF ablation, and the immunological effect induced by nsPEF will be mainly detected by tumor-associated macrophage changes. The MR will be used to monitor the distribution of SPIO in liver cancer and surrounding tissues and testify the anti-tumor immunity of SPIO. We intend to observe the effect of both treatments for liver cancer and to determine whether the two treatments have synergistic induction of anti-tumor immunity and its possible mechanism, which will provide new ideas for improving the overall efficacy of comprehensive interventional treatment for hepatocarcinoma and other malignant tumors.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1007/s10495-023-01900-x
发表时间:2023-10
期刊:Apoptosis
影响因子:7.2
作者:Cong Zhang;Tiantian Xu;Kun Ji;Shoujin Cao;Jing Ai;Junhan Pan;Yunbo Cao;Yuning Yang;
通讯作者:Cong Zhang;Tiantian Xu;Kun Ji;Shoujin Cao;Jing Ai;Junhan Pan;Yunbo Cao;Yuning Yang;
DOI:10.1002/mc.23568
发表时间:2023-05
期刊:Molecular Carcinogenesis
影响因子:4.6
作者:Cong Zhang;Tiantian Xu;Kun Ji;S. Cao;Yunbo Cao;Jing Ai;Li Jing;Junhui Sun
通讯作者:Cong Zhang;Tiantian Xu;Kun Ji;S. Cao;Yunbo Cao;Jing Ai;Li Jing;Junhui Sun
Protein-Crowned Micelles for Targeted and Synergistic Tumor-Associated Macrophage Reprogramming to Enhance Cancer Treatment
蛋白质冠胶束用于靶向和协同肿瘤相关巨噬细胞重编程以增强癌症治疗
DOI:10.1021/acs.nanolett.2c00901
发表时间:2022
期刊:Nano Letters
影响因子:10.8
作者:Jun-Hui Sun;Xiaoling Liang;Manying Cai;Libiao Yan;Zhengju Chen;Lei Guo;Li Jing;Yupeng Wang;Dongfang Zhou
通讯作者:Dongfang Zhou
DOI:--
发表时间:2022
期刊:中国介入影像与治疗学
影响因子:--
作者:高绍;王宏亮;聂春晖;张岳林;周坦洋;余子牛;杨月;孙军辉
通讯作者:孙军辉
纳米铁连接CD34×AFP双特异抗体介导内皮祖细胞携带内皮抑素/自杀融合基因治疗肝癌的研究
  • 批准号:
    81371658
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    孙军辉
  • 依托单位:
内皮前体细胞导向内皮抑素基因抗肝癌肿瘤血管生成治疗及其活体监测体系研究
  • 批准号:
    30901446
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2009
  • 负责人:
    孙军辉
  • 依托单位:
国内基金
海外基金